Home/F-star Therapeutics/Neil Brewis, Ph.D.
NB

Neil Brewis, Ph.D.

Co-founder, former Chief Scientific Officer

F-star Therapeutics

Therapeutic Areas

F-star Therapeutics Pipeline

DrugIndicationPhase
FS118Metastatic, PD-1 resistant cancers (e.g., Head & Neck, DLBCL)Phase 2
FS222Advanced solid tumorsPhase 1
FS120Advanced solid tumorsPhase 1